Rigel Pharmaceuticals (RIGL) Retained Earnings (2010 - 2026)
Rigel Pharmaceuticals' quarterly Retained Earnings came in at -$128000.0 in Q1 2026, up 99.99% year-on-year from -$64003.0 in Q1 2025, and up 99.99% quarter-over-quarter from -$1.0 billion in Q4 2025.
Rigel Pharmaceuticals has reported Retained Earnings for 17 years, with the latest figure at -$128000.0 in Q1 2026.
- For the quarter ending Q1 2026, Retained Earnings rose 99.99% year-over-year to -$128000.0; the trailing twelve-month figure through Mar 2026 stood at -$128000.0 (up 99.99% YoY), and the FY2025 full-year result was -$1.0 billion, down 10230510.0% from the prior year.
- Retained Earnings for Q1 2026 stood at -$128000.0, up from -$1.0 billion in the prior quarter.
- The five-year high for Retained Earnings was $96000.0 in Q3 2025, with the low at -$1.4 billion in Q2 2024.
- Average Retained Earnings over 5 years is -$717.8 million, with a median of -$1.0 billion recorded in 2025.
- Peak annual rise in Retained Earnings reached 100.01% in 2025, while the deepest fall reached 10230510.0% in 2025.
- Tracing RIGL's Retained Earnings over 5 years: stood at -$153000.0 in 2022, then slumped by 919867.32% to -$1.4 billion in 2023, then jumped by 100.0% to $10000.0 in 2024, then slumped by 10230510.0% to -$1.0 billion in 2025, then jumped by 99.99% to -$128000.0 in 2026.
- The last three Retained Earnings figures came in at -$128000.0 (Q1 2026), -$1.0 billion (Q4 2025), and $96000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -211.85 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | -153.89 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 1.00 Bn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | -438.66 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -279.00 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 14.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 130.89 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 36.42 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -24.89 Mn |
| 10 | Rigel Pharmaceuticals | 551.62 Mn | 404.94 Mn | 54.21 Mn | -128,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -128,000.00 |
| Dec 31, 2025 | -1.02 Bn |
| Sep 30, 2025 | 96,000.00 |
| Jun 30, 2025 | 6,000.00 |
| Mar 31, 2025 | -1.38 Bn |
| Dec 31, 2024 | 10,000.00 |
| Sep 30, 2024 | -1.40 Bn |
| Jun 30, 2024 | -1.42 Bn |
| Mar 31, 2024 | -1.42 Bn |
| Dec 31, 2023 | -1.41 Bn |
| Sep 30, 2023 | -1.41 Bn |
| Jun 30, 2023 | -25,000.00 |
| Mar 31, 2023 | -1.40 Bn |
| Dec 31, 2022 | -153,000.00 |
| Sep 30, 2022 | -286,000.00 |
| Jun 30, 2022 | -438,000.00 |
| Mar 31, 2022 | -1.35 Bn |
| Dec 31, 2021 | -1.32 Bn |
| Sep 30, 2021 | -1.30 Bn |
| Jun 30, 2021 | -1.28 Bn |
| Mar 31, 2021 | -1.27 Bn |
| Dec 31, 2020 | -1.31 Bn |
| Sep 30, 2020 | 2,000.00 |
| Jun 30, 2020 | -1.27 Bn |
| Mar 31, 2020 | -1.25 Bn |
| Dec 31, 2019 | 23,000.00 |
| Sep 30, 2019 | -1.26 Bn |
| Jun 30, 2019 | -1.25 Bn |
| Mar 31, 2019 | -1.23 Bn |
| Dec 31, 2018 | -24,000.00 |
| Sep 30, 2018 | -1.21 Bn |
| Jun 30, 2018 | -49,000.00 |
| Mar 31, 2018 | -1.16 Bn |
| Dec 31, 2017 | -1.14 Bn |
| Sep 30, 2017 | -7,000.00 |
| Jun 30, 2017 | -19,000.00 |
| Mar 31, 2017 | -1.08 Bn |
| Dec 31, 2016 | -18,000.00 |
| Sep 30, 2016 | -1.05 Bn |
| Jun 30, 2016 | -1.02 Bn |
| Mar 31, 2016 | -1.01 Bn |
| Dec 31, 2015 | -44,000.00 |
| Sep 30, 2015 | 25,000.00 |
| Jun 30, 2015 | 11,000.00 |
| Mar 31, 2015 | -958.38 Mn |
| Dec 31, 2014 | -7,000.00 |
| Sep 30, 2014 | 16,000.00 |
| Jun 30, 2014 | -896.97 Mn |
| Mar 31, 2014 | -871.58 Mn |
| Dec 31, 2013 | 47,000.00 |
| Sep 30, 2013 | -832.41 Mn |
| Jun 30, 2013 | 17,000.00 |
| Mar 31, 2013 | -785.82 Mn |
| Dec 31, 2012 | 82,000.00 |
| Sep 30, 2012 | 106,000.00 |
| Jun 30, 2012 | 37,000.00 |
| Mar 31, 2012 | 25,000.00 |
| Dec 31, 2011 | -661.41 Mn |
| Sep 30, 2011 | -635.62 Mn |
| Jun 30, 2011 | -617.69 Mn |
| Dec 31, 2010 | -575.43 Mn |